로딩 중…
지수 로딩 중…
Neurogene Inc.
NGNE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$31.53+2.40%
2026-06-18
Price Chart
Neurogene Inc.+72.30%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $498M |
| Revenue | $0.00 |
| Net Income | $-99M |
| Total Assets | $263M |
| Net Assets | $238M |
| Value | |
| P/B | 2.10x |
| FCF Yield | -16.58% |
| Profitability | |
| ROE | -41.48% |
| ROA | -37.48% |
| Revenue Growth | -100.00% |
| Financial Health | |
| Debt Ratio | 10.66% |
| Total Debt | $9M |
| FCF | $-83M |
| Cash | $124M |
| Current Ratio | 13.08x |
| Performance | |
| 1Y Return | 72.30% |
| 1M Return | 17.30% |
| From 52W High | -15.40% |
| 1Y MDD | -52.37% |
| Trading | |
| Volume | 282,971 shares |
| Trading Value | $9M |
| Per Share | |
| EPS | $-3.10 |
| BPS | $12.54 |